Activity of topical antimicrobial agents against multidrug-resistant bacteria recovered from burn patients |
| |
Authors: | Jessie S. Glasser Charles H. Guymon Katrin Mende Steven E. Wolf Duane R. Hospenthal Clinton K. Murray |
| |
Affiliation: | 1. San Antonio Military Medical Center, Fort Sam Houston, TX, United States;2. US Army Institute of Surgical Research, Fort Sam Houston, TX, United States;3. Infectious Disease Clinical Research Program, Bethesda, MD, United States;4. University of Texas Health Science Center at San Antonio, San Antonio, TX, United States;5. Uniformed Services University of the Health Sciences, Bethesda, MD, United States |
| |
Abstract: | BackgroundTopical antimicrobials are employed for prophylaxis and treatment of burn wound infections despite no established susceptibility breakpoints, which are becoming vital in an era of multidrug-resistant (MDR) bacteria. We compared two methods of determining topical antimicrobial susceptibilities.MethodsIsolates of Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum beta-lactamase (ESBL) producing Klebsiella pneumoniae, and Acinetobacter baumanii-calcoaceticus (ABC) from burn patients were tested using broth microdilution and agar well diffusion to determine minimum inhibitory concentrations (MICs) and zones of inhibition (ZI). Isolates had systemic antibiotic resistance and clonality determined. MDR included resistance to antibiotics in three or more classes.ResultsWe assessed 22 ESBL-producing K. pneumoniae, 20 ABC (75% MDR), 20 P. aeruginosa (45% MDR), and 20 MRSA isolates. The most active agents were mupirocin for MRSA and mafenide acetate for the gram-negatives with moderate MICs/ZI found with silver sulfadiazene, silver nitrate, and honey. MDR and non-MDR isolates had similar topical resistance. There was no clonality associated with resistance patterns.ConclusionDespite several methods to test bacteria for topical susceptibility, no defined breakpoints exist and standards need to be established. We recommend continuing to use silver products for prophylaxis against gram-negatives and mafenide acetate for treatment, and mupirocin for MRSA. |
| |
Keywords: | Burn Topical |
本文献已被 ScienceDirect 等数据库收录! |
|